News & Updates
Filter by Specialty:
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
The presence of erectile dysfunction (ED) does not appear to confer an increased risk of cardiovascular disease (CVD) and mortality in men with diabetes mellitus (DM), with comparable risk of adverse cardiovascular events among users and nonusers of phosphodiesterase-5 inhibitors (PDE5-Is), which are used to manage ED, according to a study.
PDE5-I use poses no excess cardiovascular, mortality risk in diabetic men with ED
20 Sep 2022
Chinese heart-healthy diet effective for lowering BP in Chinese adults
The cuisine-based Chinese heart-healthy (CHH) diet was effective, palatable, and cost-effective in reducing blood pressure (BP) in Chinese adults with mild hypertension, findings from the DECIDE*-Diet trial suggest.
Chinese heart-healthy diet effective for lowering BP in Chinese adults
19 Sep 2022
SGLT2 inhibitors help prevent new-onset AF in diabetic Asians
Use of sodium-glucose cotransporter 2 inhibitors (SGLT2is) may reduce the risk of new-onset atrial fibrillation (AF) relative to glucagon-like peptide-1 receptor agonists (GLP-1RAs) in Asian patients with type 2 diabetes mellitus (T2DM) in a real-world practice, reports a recent study.
SGLT2 inhibitors help prevent new-onset AF in diabetic Asians
18 Sep 2022
Poststroke statin treatment confers survival benefits for cancer patients
Statin treatment following ischaemic stroke appears to extend its benefits to improved survival in patients who also have had cancer, a study has found.